NO952208L - Amin-derivater - Google Patents

Amin-derivater

Info

Publication number
NO952208L
NO952208L NO952208A NO952208A NO952208L NO 952208 L NO952208 L NO 952208L NO 952208 A NO952208 A NO 952208A NO 952208 A NO952208 A NO 952208A NO 952208 L NO952208 L NO 952208L
Authority
NO
Norway
Prior art keywords
4alkyl
pct
optionally substituted
halogen
phenyl
Prior art date
Application number
NO952208A
Other languages
English (en)
Norwegian (no)
Other versions
NO952208D0 (no
Inventor
Duncan Robert Armour
Philip Charles Box
Pritom Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO952208D0 publication Critical patent/NO952208D0/no
Publication of NO952208L publication Critical patent/NO952208L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO952208A 1992-12-05 1995-06-02 Amin-derivater NO952208L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225492A GB9225492D0 (en) 1992-12-05 1992-12-05 Amine derivatives
PCT/EP1993/003381 WO1994013648A1 (en) 1992-12-05 1993-12-02 1,4-benzodiazepine derivatives and their use as cck-modulators

Publications (2)

Publication Number Publication Date
NO952208D0 NO952208D0 (no) 1995-06-02
NO952208L true NO952208L (no) 1995-08-02

Family

ID=10726205

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952208A NO952208L (no) 1992-12-05 1995-06-02 Amin-derivater

Country Status (29)

Country Link
US (1) US5569654A (zh)
EP (1) EP0672037B1 (zh)
JP (1) JPH08504200A (zh)
KR (1) KR950704270A (zh)
CN (1) CN1093085A (zh)
AT (1) ATE168102T1 (zh)
AU (1) AU688295B2 (zh)
BG (1) BG99696A (zh)
BR (1) BR9307580A (zh)
CA (1) CA2150461A1 (zh)
CZ (1) CZ138495A3 (zh)
DE (1) DE69319614D1 (zh)
EC (1) ECSP941085A (zh)
FI (1) FI952709A (zh)
GB (1) GB9225492D0 (zh)
HU (1) HUT71339A (zh)
IL (1) IL107869A (zh)
MX (1) MX9307654A (zh)
NO (1) NO952208L (zh)
NZ (1) NZ258874A (zh)
OA (1) OA10161A (zh)
PE (1) PE54294A1 (zh)
PL (1) PL309281A1 (zh)
RO (1) RO114446B1 (zh)
RU (1) RU95114528A (zh)
SK (1) SK74195A3 (zh)
TW (1) TW237450B (zh)
WO (1) WO1994013648A1 (zh)
ZA (1) ZA939068B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5428157A (en) * 1993-11-22 1995-06-27 Merck & Co., Inc. 3-acylaminobenzodiazepines
WO1995028399A1 (en) * 1994-04-15 1995-10-26 Glaxo Wellcome Inc. A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
AUPO284396A0 (en) * 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
US6369063B1 (en) 1997-04-14 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU747531B2 (en) 1997-04-14 2002-05-16 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) * 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7297346B2 (en) * 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
EP1824843A2 (en) * 2004-12-07 2007-08-29 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
US7741479B2 (en) * 2004-12-07 2010-06-22 Locus Pharmaceuticals, Inc. Urea inhibitors of MAP kinases
JP2009522363A (ja) * 2006-01-04 2009-06-11 ローカス ファーマシューティカルズ、インク． プロテインキナーゼの阻害剤
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents

Also Published As

Publication number Publication date
BR9307580A (pt) 1999-06-29
CZ138495A3 (en) 1995-12-13
WO1994013648A1 (en) 1994-06-23
MX9307654A (es) 1994-06-30
ZA939068B (en) 1994-08-09
RO114446B1 (ro) 1999-04-30
FI952709A (fi) 1995-08-01
CA2150461A1 (en) 1994-06-23
NO952208D0 (no) 1995-06-02
RU95114528A (ru) 1997-06-10
HU9501622D0 (en) 1995-08-28
FI952709A0 (fi) 1995-06-02
GB9225492D0 (en) 1993-01-27
ATE168102T1 (de) 1998-07-15
HUT71339A (en) 1995-11-28
CN1093085A (zh) 1994-10-05
AU5694894A (en) 1994-07-04
KR950704270A (ko) 1995-11-17
IL107869A (en) 1998-10-30
BG99696A (bg) 1996-01-31
SK74195A3 (en) 1995-11-08
US5569654A (en) 1996-10-29
PL309281A1 (en) 1995-10-02
PE54294A1 (es) 1995-01-06
OA10161A (en) 1996-12-18
ECSP941085A (es) 1994-12-15
IL107869A0 (en) 1994-04-12
NZ258874A (en) 1996-09-25
DE69319614D1 (de) 1998-08-13
EP0672037B1 (en) 1998-07-08
JPH08504200A (ja) 1996-05-07
AU688295B2 (en) 1998-03-12
TW237450B (zh) 1995-01-01
EP0672037A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
NO952208L (no) Amin-derivater
CO4970780A1 (es) Nuevos compuestos heterociclicos de piridazina
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
NZ503076A (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives and addition salts thereof, with antagonism against amino acid receptors (particularly AMPA receptor) and processes for their preparation
ATE156804T1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
BG97221A (bg) Ортозаместени бифениламидини и бифенилизанидини и съдържащите ги антидиабетични или хипогликемични средства
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
PE20020253A1 (es) Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos
MY118638A (en) 1,5-benzodiazepine derivatives
ATE199543T1 (de) Bibphenylamid-derivate als 5-ht1d-antagonisten
CO5540322A2 (es) Nuevos derivados heterociclicos que comprenden un anillo de tetrahidroisoquinolina y uso farmaceutico de los mismos
DE69936572D1 (de) Benzisoxazolderivate mit d4-antagonistischer wirkung
FR2632639B1 (fr) Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
NO961404L (no) 4-indolylpiperazinyl-derivater
ATE172454T1 (de) Pyridazinon derivate mit pharmazeutischer wirkung
DK1220848T3 (da) N-arylmethylthioanilid-forbindelser, som er nyttige til inhibition af replikationen af HIV
NZ337749A (en) Benzimidazole derivative and their use in allergy-related disease
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
CO5031252A1 (es) Compuestos
DE69414117D1 (de) 1,5-benzodiazepin-derivate verwendbar als cck oder gastrin antagonisten
TH15971A (th) อนุพันธ์ของแอมีน
ECSP920821A (es) Composiciones heterocyclicas